Skip to main content
Erschienen in: World Journal of Surgery 4/2012

01.04.2012

Intraoperative Blood Transfusion Contributes to Decreased Long-Term Survival of Patients With Esophageal Cancer

verfasst von: Yoshihiro Komatsu, Hajime Orita, Mutsumi Sakurada, Hiroshi Maekawa, Toshitaka Hoppo, Koichi Sato

Erschienen in: World Journal of Surgery | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Several prognostic factors for patients who have undergone esophagectomy owing to esophageal squamous cell carcinoma have been suggested, including intraoperative blood loss. There are few data, however, suggesting such an association with the prognosis following radical esophagectomy.

Methods

Patients with esophageal squamous cell carcinoma who underwent radical esophagectomy were divided into two groups based on the median value of the intraoperative blood loss (510 g). A multivariate Cox proportional-hazard regression analysis was performed to determine if intraoperative blood loss could be an independent prognostic factor for long-term survival following radical esophagectomy. Kaplan–Meier survival analysis with a log-rank test was performed between the groups.

Results

From April 2005 to May 2009, a total of 37 patients underwent radical esophagectomy for the treatment of esophageal squamous cell carcinoma at the Juntendo Shizuoka Hospital and were assigned either to one of two groups: those with ≥510 g blood loss [bleeding group (BG), n = 19] or of those with <510 g blood loss [less bleeding group (LBG), n = 18]. The distribution of the stage of disease, the number of positive lymph nodes, and the presence of lymphatic and vascular invasion was comparable between the groups, but the Kaplan–Meier survival analysis demonstrated that survival was significantly worse in the BG group than in the LBG group (p = 0.00295). This was supported by the multivariate analysis, which indicated that intraoperative blood loss was independently associated with long-term survival after radical esophagectomy.

Conclusions

Intraoperative blood loss could be a useful prognostic factor following radical esophagectomy in patients with esophageal squamous cell carcinoma.
Literatur
1.
Zurück zum Zitat Jemal A, Siegel R, Ward E et al (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249PubMedCrossRef Jemal A, Siegel R, Ward E et al (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249PubMedCrossRef
2.
Zurück zum Zitat Cohen DJ, Ajani J (2011) An expert opinion on esophageal cancer therapy. Expert Opin Pharmacother 12:225–239PubMedCrossRef Cohen DJ, Ajani J (2011) An expert opinion on esophageal cancer therapy. Expert Opin Pharmacother 12:225–239PubMedCrossRef
3.
Zurück zum Zitat Demeester SR (2009) Epidemiology and biology of esophageal cancer. Gastrointest Cancer Res 3(Suppl):S2–S5PubMed Demeester SR (2009) Epidemiology and biology of esophageal cancer. Gastrointest Cancer Res 3(Suppl):S2–S5PubMed
4.
Zurück zum Zitat Osugi H, Takemura M, Takada N et al (2002) Prognostic factors after oesophagectomy and extended lymphadenectomy for squamous oesophageal cancer. Br J Surg 89:909–913PubMedCrossRef Osugi H, Takemura M, Takada N et al (2002) Prognostic factors after oesophagectomy and extended lymphadenectomy for squamous oesophageal cancer. Br J Surg 89:909–913PubMedCrossRef
5.
Zurück zum Zitat Kitagawa Y (2008) Therapeutic strategies for advanced respectable esophageal cancer. Nippon Geka Gakkai Zasshi 109:333–337PubMed Kitagawa Y (2008) Therapeutic strategies for advanced respectable esophageal cancer. Nippon Geka Gakkai Zasshi 109:333–337PubMed
6.
Zurück zum Zitat Higuchi K, Koizumi W, Tanabe S et al (2009) Current management of esophageal squamous-cell carcinoma in Japan and other countries. Gastrointest Cancer Res 3:153–161PubMed Higuchi K, Koizumi W, Tanabe S et al (2009) Current management of esophageal squamous-cell carcinoma in Japan and other countries. Gastrointest Cancer Res 3:153–161PubMed
7.
Zurück zum Zitat Tsurumaru M, Kajiyama Y, Udagawa H et al (2001) Outcomes of extended lymph node dissection for squamous cell carcinoma of the thoracic esophagus. Ann Thorac Cardiovasc Surg 7:325–329PubMed Tsurumaru M, Kajiyama Y, Udagawa H et al (2001) Outcomes of extended lymph node dissection for squamous cell carcinoma of the thoracic esophagus. Ann Thorac Cardiovasc Surg 7:325–329PubMed
8.
Zurück zum Zitat Tachibana M, Kinugasa S, Dhar DK et al (1999) Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Surg Oncol 72:88–93PubMedCrossRef Tachibana M, Kinugasa S, Dhar DK et al (1999) Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Surg Oncol 72:88–93PubMedCrossRef
9.
Zurück zum Zitat Tachibana M, Kinugasa S, Dhar DK et al (1999) Prognostic factors in T1 and T2 squamous cell carcinoma of the thoracic esophagus. Arch Surg 134:50–54PubMedCrossRef Tachibana M, Kinugasa S, Dhar DK et al (1999) Prognostic factors in T1 and T2 squamous cell carcinoma of the thoracic esophagus. Arch Surg 134:50–54PubMedCrossRef
10.
Zurück zum Zitat Hu Y, Zheng B, Rong TH et al (2010) Prognostic analysis of the patients with stage-III esophageal squamous cell carcinoma after radical esophagectomy. Chin J Cancer 29:178–183PubMed Hu Y, Zheng B, Rong TH et al (2010) Prognostic analysis of the patients with stage-III esophageal squamous cell carcinoma after radical esophagectomy. Chin J Cancer 29:178–183PubMed
11.
Zurück zum Zitat Katz SC, Shia J, Liau KH et al (2009) Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 249:617–623PubMedCrossRef Katz SC, Shia J, Liau KH et al (2009) Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 249:617–623PubMedCrossRef
12.
Zurück zum Zitat Nagai S, Fujii T, Kodera Y et al (2011) Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas. Pancreas 40:3–9PubMedCrossRef Nagai S, Fujii T, Kodera Y et al (2011) Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas. Pancreas 40:3–9PubMedCrossRef
13.
Zurück zum Zitat Oefelein MG, Colangelo LA, Rademaker AW et al (1995) Intraoperative blood loss and prognosis in prostate cancer patients undergoing radical retropubic prostatectomy. J Urol 154(Pt 1):442–447PubMed Oefelein MG, Colangelo LA, Rademaker AW et al (1995) Intraoperative blood loss and prognosis in prostate cancer patients undergoing radical retropubic prostatectomy. J Urol 154(Pt 1):442–447PubMed
14.
Zurück zum Zitat Tartter PI (1992) The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 216:633–638PubMedCrossRef Tartter PI (1992) The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 216:633–638PubMedCrossRef
15.
Zurück zum Zitat Ojima T, Iwahashi M, Nakamori M et al (2009) Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy. J Gastrointest Surg 13:1821–1830PubMedCrossRef Ojima T, Iwahashi M, Nakamori M et al (2009) Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy. J Gastrointest Surg 13:1821–1830PubMedCrossRef
16.
Zurück zum Zitat Takemura M, Osugi H, Higashino M et al (2005) Effect of substituting allogenic blood transfusion with autologous blood transfusion on outcomes after radical oesophagectomy for cancer. Ann Thorac Cardiovasc Surg 11:293–300PubMed Takemura M, Osugi H, Higashino M et al (2005) Effect of substituting allogenic blood transfusion with autologous blood transfusion on outcomes after radical oesophagectomy for cancer. Ann Thorac Cardiovasc Surg 11:293–300PubMed
17.
Zurück zum Zitat Tachibana M, Tabara H, Kotoh T et al (1999) Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer. Am J Gastroenterol 94:757–765PubMedCrossRef Tachibana M, Tabara H, Kotoh T et al (1999) Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer. Am J Gastroenterol 94:757–765PubMedCrossRef
18.
Zurück zum Zitat Peyre CG, Hagen JA, DeMeester SR et al (2008) Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann Surg 248:979–985PubMedCrossRef Peyre CG, Hagen JA, DeMeester SR et al (2008) Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann Surg 248:979–985PubMedCrossRef
19.
Zurück zum Zitat Mariette C, Piessen G, Briez N et al (2008) The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 247:365–371PubMedCrossRef Mariette C, Piessen G, Briez N et al (2008) The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 247:365–371PubMedCrossRef
20.
Zurück zum Zitat Altorki N, Kent M, Ferrara C et al (2002) Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 236:177–183PubMedCrossRef Altorki N, Kent M, Ferrara C et al (2002) Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 236:177–183PubMedCrossRef
21.
Zurück zum Zitat Lerut T, Nafteux P, Moons J et al (2004) Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome—a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 240:962–972; discussion 972–964PubMedCrossRef Lerut T, Nafteux P, Moons J et al (2004) Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome—a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 240:962–972; discussion 972–964PubMedCrossRef
22.
Zurück zum Zitat Nishihira T, Hirayama K, Mori S (1998) A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 175:47–51PubMedCrossRef Nishihira T, Hirayama K, Mori S (1998) A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 175:47–51PubMedCrossRef
23.
Zurück zum Zitat Kobayashi S, Asano T, Ochiai T (2001) A proposal of no-touch isolation technique in pancreatoduodenectomy for periampullary carcinomas. Hepatogastroenterology 48:372–374PubMed Kobayashi S, Asano T, Ochiai T (2001) A proposal of no-touch isolation technique in pancreatoduodenectomy for periampullary carcinomas. Hepatogastroenterology 48:372–374PubMed
24.
Zurück zum Zitat Dhar DK, Kubota H, Tachibana M et al (2000) Long-term survival of transmural advanced gastric carcinoma following curative resection: multivariate analysis of prognostic factors. World J Surg 24:588–593; discussion 593–584. doi:10.1007/s002689910099 PubMedCrossRef Dhar DK, Kubota H, Tachibana M et al (2000) Long-term survival of transmural advanced gastric carcinoma following curative resection: multivariate analysis of prognostic factors. World J Surg 24:588–593; discussion 593–584. doi:10.​1007/​s002689910099 PubMedCrossRef
25.
Zurück zum Zitat Kamei T, Kitayama J, Yamashita H et al (2009) Intraoperative blood loss is a critical risk factor for peritoneal recurrence after curative resection of advanced gastric cancer. World J Surg 33:1240–1246. doi:10.1007/s00268-009-9979-4 PubMedCrossRef Kamei T, Kitayama J, Yamashita H et al (2009) Intraoperative blood loss is a critical risk factor for peritoneal recurrence after curative resection of advanced gastric cancer. World J Surg 33:1240–1246. doi:10.​1007/​s00268-009-9979-4 PubMedCrossRef
26.
Zurück zum Zitat Bruns CJ, Schafer H, Wolfgarten B et al (1996) Einfluss des intraoperativen Blutverlustes auf die Funktion der naturlichen Killerzellen bei Tumoren des oberen Gastrointestinaltraktes [Effect of intraoperative blood loss on the function of natural killer cells in tumors of the upper gastrointestinal tract]. Langenbecks Arch Chir Suppl Kongressbd 113:146–149PubMed Bruns CJ, Schafer H, Wolfgarten B et al (1996) Einfluss des intraoperativen Blutverlustes auf die Funktion der naturlichen Killerzellen bei Tumoren des oberen Gastrointestinaltraktes [Effect of intraoperative blood loss on the function of natural killer cells in tumors of the upper gastrointestinal tract]. Langenbecks Arch Chir Suppl Kongressbd 113:146–149PubMed
27.
Zurück zum Zitat Roumen RM, Hendriks T, van der Ven-Jongekrijg J et al (1993) Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma: relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 218:769–776PubMedCrossRef Roumen RM, Hendriks T, van der Ven-Jongekrijg J et al (1993) Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma: relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 218:769–776PubMedCrossRef
28.
Zurück zum Zitat Cue JI, Peyton JC, Malangoni MA (1992) Does blood-transfusion or hemorrhagic-shock induce immunosuppression. J Trauma 32:613–617PubMedCrossRef Cue JI, Peyton JC, Malangoni MA (1992) Does blood-transfusion or hemorrhagic-shock induce immunosuppression. J Trauma 32:613–617PubMedCrossRef
29.
Zurück zum Zitat Younes RN, Rogatko A, Brennan MF (1991) The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg 214:107–113PubMedCrossRef Younes RN, Rogatko A, Brennan MF (1991) The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg 214:107–113PubMedCrossRef
30.
Zurück zum Zitat Ydy LR, Slhessarenko N, de Aguilar-Nascimento JE (2007) Effect of perioperative allogeneic red blood cell transfusion on the immune-inflammatory response after colorectal cancer resection. World J Surg 31:2044–2051. doi:10.1007/s00268-007-9159-3 PubMedCrossRef Ydy LR, Slhessarenko N, de Aguilar-Nascimento JE (2007) Effect of perioperative allogeneic red blood cell transfusion on the immune-inflammatory response after colorectal cancer resection. World J Surg 31:2044–2051. doi:10.​1007/​s00268-007-9159-3 PubMedCrossRef
31.
Zurück zum Zitat Dresner SM, Lamb PJ, Shenfine J et al (2000) Prognostic significance of peri-operative blood transfusion following radical resection for oesophageal carcinoma. Eur J Surg Oncol 26:492–497PubMedCrossRef Dresner SM, Lamb PJ, Shenfine J et al (2000) Prognostic significance of peri-operative blood transfusion following radical resection for oesophageal carcinoma. Eur J Surg Oncol 26:492–497PubMedCrossRef
32.
Zurück zum Zitat Lieberman MD, Shou J, Sigal RK et al (1990) Transfusion-induced immunosuppression results in diminished host survival in a murine neuroblastoma model. J Surg Res 48:498–503PubMedCrossRef Lieberman MD, Shou J, Sigal RK et al (1990) Transfusion-induced immunosuppression results in diminished host survival in a murine neuroblastoma model. J Surg Res 48:498–503PubMedCrossRef
33.
Zurück zum Zitat Kaplan J, Sarnaik S, Gitlin J et al (1984) Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 64:308–310PubMed Kaplan J, Sarnaik S, Gitlin J et al (1984) Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 64:308–310PubMed
34.
Zurück zum Zitat Osugi H, Takemura M, Higashino M et al (2003) Causes of death and pattern of recurrence after esophagectomy and extended lymphadenectomy for squamous cell carcinoma of the thoracic esophagus. Oncol Rep 10:81–87PubMed Osugi H, Takemura M, Higashino M et al (2003) Causes of death and pattern of recurrence after esophagectomy and extended lymphadenectomy for squamous cell carcinoma of the thoracic esophagus. Oncol Rep 10:81–87PubMed
Metadaten
Titel
Intraoperative Blood Transfusion Contributes to Decreased Long-Term Survival of Patients With Esophageal Cancer
verfasst von
Yoshihiro Komatsu
Hajime Orita
Mutsumi Sakurada
Hiroshi Maekawa
Toshitaka Hoppo
Koichi Sato
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 4/2012
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-012-1433-3

Weitere Artikel der Ausgabe 4/2012

World Journal of Surgery 4/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.